For example, although reduction of acromegaly disease activity might lead to improvements in insulin sensitivity, worsening of hyperglycaemia can occur during therapy, largely owing to inhibition of insulin secretion by SRLs (MQ). This evidence concerns the gene INS and acromegaly.